iGLASS: imaging integration into the Glioma Longitudinal Analysis Consortium

Spyridon Bakas^{1

2

3}, David Ryan Ormond⁴, Kristin D Alfaro-Munoz⁵, Marion Smits⁶, Lee Alex Donald Cooper⁷, Roel Verhaak⁸, Laila M Poisson⁹

Affiliations

¹ Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
⁵ Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁶ Department of Radiology and Nuclear Medicine, Erasmus MC‒University Medical Center Rotterdam, Rotterdam, Netherlands.
⁷ Department of Pathology, Feinberg School of Medicine, Northwestern Medicine, Northwestern University, Chicago, Illinois, USA.
⁸ The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
⁹ Henry Ford Cancer Institute, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.

Spyridon Bakas et al. Neuro Oncol. 2020.

. 2020 Oct 14;22(10):1545-1546.

doi: 10.1093/neuonc/noaa160.

Spyridon Bakas^{1

2

3}, David Ryan Ormond⁴, Kristin D Alfaro-Munoz⁵, Marion Smits⁶, Lee Alex Donald Cooper⁷, Roel Verhaak⁸, Laila M Poisson⁹

¹ Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
⁵ Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁶ Department of Radiology and Nuclear Medicine, Erasmus MC‒University Medical Center Rotterdam, Rotterdam, Netherlands.
⁷ Department of Pathology, Feinberg School of Medicine, Northwestern Medicine, Northwestern University, Chicago, Illinois, USA.
⁸ The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
⁹ Henry Ford Cancer Institute, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.

No abstract available

Keywords: GLASS; Glioma; glioblastoma; iGLASS; imaging; radiogenomics.

References

1. Consortium TG. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium. Neuro Oncol. 2018;20(7):873–884. - PMC - PubMed
1. Barthel FP, Johnson KC, Varn FS, et al. ; GLASS Consortium Longitudinal molecular trajectories of diffuse glioma in adults. Nature. 2019;576(7785):112–120. - PMC - PubMed
1. Fathi Kazerooni A, Bakas S, Saligheh Rad H, Davatzikos C. Imaging signatures of glioblastoma molecular characteristics: a radiogenomics review. J Magn Reson Imaging. 2020;52(1):54–69. - PMC - PubMed
1. Incekara F, van der Voort SR, Dubbink HJ, et al. Topographical mapping of 436 newly diagnosed IDH wildtype glioblastoma with vs. without MGMT promoter methylation. Front Oncol. 2020;10:596. - PMC - PubMed
1. Schwarz CG, Kremers WK, Therneau TM, et al. Identification of anonymous MRI research participants with face-recognition software. N Engl J Med. 2019;381(17):1684–1686. - PMC - PubMed